288 related articles for article (PubMed ID: 36255682)
41. Age-Related Decline in Gangliosides GM1 and GD1a in Non-CNS Tissues of Normal Mice: Implications for Peripheral Symptoms of Parkinson's Disease.
Chowdhury S; Wu G; Lu ZH; Kumar R; Ledeen R
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672717
[TBL] [Abstract][Full Text] [Related]
42. Ganglioside GM1 and the Central Nervous System.
Guo Z
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298512
[TBL] [Abstract][Full Text] [Related]
43. Increased cerebrospinal fluid ganglioside GM1 concentrations indicating neuronal involvement in all stages of HIV-1 infection.
Gisslén M; Hagberg L; Norkrans G; Lekman A; Fredman P
J Neurovirol; 1997 Apr; 3(2):148-52. PubMed ID: 9111177
[TBL] [Abstract][Full Text] [Related]
44. Absence of ganglioside GM1 in astroglial cells from 21-day old rat brain: immunohistochemical, histochemical, and biochemical studies.
Asou H; Brunngraber EG
Neurochem Res; 1983 Aug; 8(8):1045-57. PubMed ID: 6194443
[TBL] [Abstract][Full Text] [Related]
45. GD1b-specific antibodies may bind to complex of GQ1b and GM1, causing ataxia.
Yuki N; Fukami Y; Yanaka C; Koike S; Hirata K
J Neurol; 2014 Aug; 261(8):1565-9. PubMed ID: 24859332
[TBL] [Abstract][Full Text] [Related]
46. Brain gangliosides in dementia of the Alzheimer type.
Crino PB; Ullman MD; Vogt BA; Bird ED; Volicer L
Arch Neurol; 1989 Apr; 46(4):398-401. PubMed ID: 2705899
[TBL] [Abstract][Full Text] [Related]
47. Assignment of the carbon-13 nuclear magnetic resonance spectra of gangliosides GM4, GM3, GM2, GM1, GD1a, GD1b, and GT1b.
Sillerud LO; Yu RK; Schafer DE
Biochemistry; 1982 Mar; 21(6):1260-71. PubMed ID: 7074082
[TBL] [Abstract][Full Text] [Related]
48. First Radiolabeling of a Ganglioside with a Positron Emitting Radionuclide:
Revunov E; Johnström P; Arakawa R; Malmquist J; Jucaite A; Defay T; Takano A; Schou M
ACS Chem Neurosci; 2020 May; 11(9):1245-1249. PubMed ID: 32324990
[TBL] [Abstract][Full Text] [Related]
49. Quantification of gangliotetraose gangliosides with cholera toxin.
Wu GS; Ledeen R
Anal Biochem; 1988 Sep; 173(2):368-75. PubMed ID: 3189815
[TBL] [Abstract][Full Text] [Related]
50. Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b.
Riboni L; Ghidoni R; Tettamanti G
J Neurochem; 1989 May; 52(5):1401-6. PubMed ID: 2709011
[TBL] [Abstract][Full Text] [Related]
51. Interaction of influenza virus with gangliosides and liposomes containing gangliosides.
Slepushkin VA; Starov AI; Bukrinskaya AG; Imbs AB; Martynova MA; Kogtev LS; Vodovozova EL; Timofeeva NG; Molotkovsky JG; Bergelson LD
Eur J Biochem; 1988 May; 173(3):599-605. PubMed ID: 3371350
[TBL] [Abstract][Full Text] [Related]
52. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
[TBL] [Abstract][Full Text] [Related]
53. Interaction of cholera toxin with gangliosides: differential effects of the oligosaccharide of ganglioside GM1 and of micellar gangliosides.
Tomasi M; Battistini A; Cardelli M; Sonnino S; D'Agnolo G
Biochemistry; 1984 May; 23(11):2520-6. PubMed ID: 6477883
[TBL] [Abstract][Full Text] [Related]
54. Tryptophan fluorescence properties of cholera toxin upon interacting with ganglioside GD1b.
Mestrallet MG; Bennun FR; Maggio B; Cumar FA
J Neurosci Res; 1984; 12(2-3):335-41. PubMed ID: 6502757
[TBL] [Abstract][Full Text] [Related]
55. siRNA-mediated knockdown of B3GALT4 decreases GM1 ganglioside expression and enhances vulnerability for neurodegeneration.
Verma M; Schneider JS
Mol Cell Neurosci; 2019 Mar; 95():25-30. PubMed ID: 30611881
[TBL] [Abstract][Full Text] [Related]
56. Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease.
Pernber Z; Blennow K; Bogdanovic N; Månsson JE; Blomqvist M
Dement Geriatr Cogn Disord; 2012; 33(2-3):174-88. PubMed ID: 22572791
[TBL] [Abstract][Full Text] [Related]
57. Role of membrane gangliosides in the binding and action of bacterial toxins.
Fishman PH
J Membr Biol; 1982; 69(2):85-97. PubMed ID: 6752418
[TBL] [Abstract][Full Text] [Related]
58. Amyloid-β induced toxicity involves ganglioside expression and is sensitive to GM1 neuroprotective action.
Kreutz F; Frozza RL; Breier AC; de Oliveira VA; Horn AP; Pettenuzzo LF; Netto CA; Salbego CG; Trindade VM
Neurochem Int; 2011 Oct; 59(5):648-55. PubMed ID: 21723896
[TBL] [Abstract][Full Text] [Related]
59. Two cases of acute anti-GM1 antibody elevations in response to exogenous GM1 without neurological symptoms.
Ala TA; Perfetti PA; Frey WH
J Neuroimmunol; 1994 Aug; 53(1):109-13. PubMed ID: 8051293
[TBL] [Abstract][Full Text] [Related]
60. Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside.
Leon A; Facci L; Toffano G; Sonnino S; Tettamanti G
J Neurochem; 1981 Aug; 37(2):350-7. PubMed ID: 6267200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
